Chamath Palihapitiya is riding high these days. Wall Street’s biggest exponent of special-purpose acquisitions companies, or SPACs, is hoping to create as much wealth as Warren Buffett. He has a pretty good track record thus far. However, the one chink in his armor is Clover Health Investments (NASDAQ:CLOV). CLOV stock is down 36% in the last
Stock Market
The times are changing in the marijuana industry. Three years ago, traders were excited for the Canadian cannabis stocks. That country was about to open up its retail marijuana market and it seemed like the possibilities were endless. Fast-forward to now, however, and the Canadian pot companies have crashed and burned while American players have
Since last November, it’s been investor perception rather than fundamentals driving price action in Palantir (NYSE:PLTR) stock. Trying to value this big data company’s shares using traditional valuation metrics has thus far been a fool’s errand. Source: Sundry Photography / Shutterstock.com You can say the stock’s rich valuation is built on its impressive growth projections.
The SPAC (special purpose acquisition company) craze of 2020 and 2021 may go down in the history books as one of the most speculative market situations in stock market history. 2021 has seen $166 billion in SPAC-led deals so far, more than double 2020’s SPACs issuance of $73 billion. There have been winners and losers
Riot Blockchain (NASDAQ:RIOT) announced on April 12 its first quarter mining production numbers. In addition, the company provided its ultimate Bitcoin (CCC:BTC-USD) production estimates based on its expected mining hash rate over the next year and a half or so to the end of 2022. As a result, it looks like RIOT stock could still
First-quarter earnings season kicked off last week. With 23% of the U.S. vaccinated, businesses steadily re-opening, and trillions of dollars of monetary fizz getting pumped into the market, it’s no surprise that investor confidence is at an all-time high. Risk-taking is the new normal. And that makes the tug-of-war between Wall Street and Main Street
When I last discussed TPG Pace Beneficial (NYSE:TPGY), I voice some skepticism regarding the special purpose acquisition company. Scheduled to reverse merge with EVBox, an electric vehicle charging solutions provider, the outside fundamentals seemed supportive for TPGY stock. Source: VanderWolf Images / Shutterstock.com After all, everybody was going crazy for electric vehicles, which bode well
Aphria (NASDAQ:APHA) stock is facing a challenging period following its third quarter earnings disappointment. Source: Shutterstock Aphria announced fiscal year 2021 third quarter financial results on April 12. The news was bad, and as a result share prices plunged. Next, on April 14, Aphria will hold a special meeting for shareholders to approve the Aphria-Tilray
Covering stocks, every once in a while an editor throws you a “Geez, Louise” assignment. That’s how it was with this request to cover C3.ai (NYSE:AI). Still, as one of the most hotly anticipated market debuts, I realized that AI stock charmed investors early on but has since left them bitterly disappointed. Source: Shutterstock When
Among the most beaten-down market sectors during the onset of the novel coronavirus was the cruise-line industry. For a while, it seemed as if the investing community hated Norwegian Cruise Line (NYSE:NCLH). The share-price rout in NCLH stock was absolutely relentless. Source: Roberto Sorin / Shutterstock.com Things certainly have changed during the past year, however. Today,
Investors are getting mixed signals on the state of the economy as we head into spring. On the one hand, investor concerns over inflation, deficit spending and certain Fed decisions continue to cause worry. Some economists fear that a rebound following the pandemic may not be as robust as previously predicted. Still others are betting
It was a manic Monday for Aphria (NASDAQ:APHA) stock, which plunged 14% to $13.92. The reason was simple: the company’s earnings were downright awful. Source: Shutterstock And the bad news spread across the cannabis sector. Stocks like Canopy Growth (NASDAQ:CGC), Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) got hit as well. So what were the numbers
The global chip shortage does not appear to be going anywhere. And it’s interrupted some big rallies in key stocks. The question is whether the hot stocks that have cooled off present buying opportunities. In some cases, they do. After all, the chip shortage should be a relatively short-term phenomenon, even if “short-term” is measured
Coinbase (NASDAQ:COIN) is scheduled to go public on April 14 in a direct listing that will see America’s largest cryptocurrency exchange sell shares directly to investors, foregoing the traditional initial public offering (IPO) process. Source: Primakov / Shutterstock.com As I write this, a reference price has yet to be set. Nasdaq will set this price
BioNTech (NASDAQ:BNTX) stock is sitting on a 48% gain in 2021. And over the last 12 months BNTX stock is up over 168%. The reason is that the company, in partnership with Pfizer (NYSE:PFE), was the first to market with a Covid-19 vaccine. Source: Shutterstock However the significance of the vaccine is about more than
Holding steady at just under $40 per share, can Nio (NYSE:NIO) stock rebound back its past highs? Don’t count on it. Sure, its recent delivery numbers may have been satisfactory. But, with shares in the China-based electric vehicle (EV) company still trading as if recent growth will carry on in the years ahead, shares have
Bill Gates appeared on CNBC on Good Friday to discuss his climate-related work for the Economic Club of New York. The conversation veered off into the wild and wooly world of special purpose acquisition companies (SPACs). Gates, an early backer of QuantumScape (NYSE:QS) and QS stock, suggested that people do what he’s doing and only
The high point for ChargePoint (NYSE:CHPT) in 2021 was when CHPT stock hit $46.30 in mid-January. Not quite an all-time high ($49.48 on Christmas Eve 2020), it’s clawed back from its March lows below $20. Source: YuniqueB / Shutterstock.com Now trading around $28 as I write this, I’m wondering if the electric vehicle (EV) charging
Genius Brands International (NASDAQ:GNUS) has really transformed itself. In the space of a little over one year, the company has raised over $140 million in cash proceeds. In addition, the company has no debt. Moreover, it has become a major independent kids’ studio and media channel. As a result, GNUS stock has risen 6.55 times
IPO investing has gotten considerably harder. While it still affords investors an opportunity in companies like Roblox (NYSE:RBLX), it’s not necessarily the same system it used to be. RBLX stock went public about a month ago on March 10 and has done well since — up about 10% from its opening print. Source: Katya Rekina/
- « Previous Page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- …
- 99
- Next Page »